Key points are not available for this paper at this time.
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTCan Controversial Nanotechnology Promise Drug Delivery?Venkat Ratnam Devadasu, Vivekanand Bhardwaj, and M. N. V. Ravi Kumar*View Author Information Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom*E-mail: email protectedCite this: Chem. Rev. 2013, 113, 3, 1686–1735Publication Date (Web):December 31, 2012Publication History Received7 February 2012Published online31 December 2012Published inissue 13 March 2013https://pubs.acs.org/doi/10.1021/cr300047qhttps://doi.org/10.1021/cr300047qreview-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views10148Altmetric-Citations172LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Drug delivery,Molecules,Nanoparticles,Pharmaceuticals,Polymers Get e-Alerts
Devadasu et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: